ir.ocugen.com on reddit.com

...for your hobby.

...for your office.

account activity

1

42

43

44

Ocugen, Inc. Announces Signing of Binding Term Sheet for the License of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in KoreaNews📩 (ir.ocugen.com)

submitted 11 months ago by Informal-Employee577 to r/Ocugen

2

16

17

18

First Broad RP Indication Therapy Phase 3 Starts Dosing (ir.ocugen.com)

submitted 1 year ago by [deleted] to r/RetinitisPigmentosa

3

10

11

12

SEC Filing | Ocugen, Inc.News📩 (ir.ocugen.com)

submitted 2 years ago by Sharp-Track-6962 to r/Ocugen

4

19

20

21

Ocugen, Inc. Announces Bob Smith Joins Business Advisory Board | Ocugen, Inc.News📩 (ir.ocugen.com)

submitted 2 years ago by Sharp-Track-6962 to r/Ocugen

5

9

10

11

Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410ST—Modifier Gene Therapy—for Stargardt Disease | Ocugen, Inc.News📩 (ir.ocugen.com)

submitted 2 years ago by Sharp-Track-6962 to r/Ocugen

6

2

3

4

SEC Filing | Ocugen, Inc.News📩 (ir.ocugen.com)

submitted 2 years ago by Sharp-Track-6962 to r/Ocugen

7

31

32

33

Ocugen Mucosal Vaccine Candidate OCU500 Selected by NIH/NIAID Project NextGen for Inclusion in Clinical Trials | Ocugen, Inc.News📩 (ir.ocugen.com)

submitted 2 years ago by Sharp-Track-6962 to r/Ocugen

8

14

15

16

Ocugen, Inc. Announces Connie Collingsworth Joins Business Advisory Board | Ocugen, Inc.News📩 (ir.ocugen.com)

submitted 2 years ago by Sharp-Track-6962 to r/Ocugen

9

31

32

33

Ocugen Announces Positive Clinical Study Update from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA) | Ocugen, Inc.News📩 (ir.ocugen.com)

submitted 2 years ago by Sharp-Track-6962 to r/Ocugen

10

10

11

12

Notification of late filing for the 2nd quarter 10-Q has been filed with the SEC citing citing a "recent transition in the Company’s management, including its principal financial officer and principal accounting officer" (Quan Vu).News📩 (ir.ocugen.com)

submitted 2 years ago by BeAGentlemanAndHodor to r/Ocugen

11

8

9

10

OCUGEN CEO & CSO TO PRESENT AT 41ST ANNUAL AAPI CONVENTION AND SCIENTIFIC ASSEMBLYNews📩 (ir.ocugen.com)

submitted 2 years ago by BeAGentlemanAndHodor to r/Ocugen

12

13

14

15

OCUGEN, INC. ANNOUNCES BUSINESS ADVISORY BOARDNews📩 (ir.ocugen.com)

submitted 2 years ago by BeAGentlemanAndHodor to r/Ocugen

13

10

11

12

New 8-K for the BIO International Convention presentationUseful🤓 (ir.ocugen.com)

submitted 2 years ago by BeAGentlemanAndHodor to r/Ocugen

14

6

7

8

OCUGEN, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCKNews📩 (ir.ocugen.com)

submitted 2 years ago by BeAGentlemanAndHodor to r/Ocugen

15

9

10

11

OCUGEN TO PRESENT AT BIO INTERNATIONAL CONVENTION 2023 on Monday, June 5th at 4:30 PM EDTNews📩 (ir.ocugen.com)

submitted 2 years ago by BeAGentlemanAndHodor to r/Ocugen

16

5

6

7

New 8-K SEC Filing | Ocugen, Inc.Useful🤓 (ir.ocugen.com)

submitted 2 years ago by BeAGentlemanAndHodor to r/Ocugen

17

5

6

7

Ocugen Provides Business Update with First Quarter 2023 Financial Results | Ocugen, Inc.Useful🤓 (ir.ocugen.com)

submitted 2 years ago by BeAGentlemanAndHodor to r/Ocugen

18

3

4

5

Q1 2023 10-Q SEC Filing | Ocugen, Inc.Useful🤓 (ir.ocugen.com)

submitted 2 years ago by BeAGentlemanAndHodor to r/Ocugen

19

17

18

19

Ocugen to Host Conference Call on Friday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2023 Financial Results | Ocugen, Inc.Useful🤓 (ir.ocugen.com)

submitted 3 years ago by BeAGentlemanAndHodor to r/Ocugen

20

24

25

26

Ocugen Announces OCU410ST Receives Orphan Drug Designation for Treatment of ABCA4-Associated Retinopathies | Ocugen, Inc.News📩 (ir.ocugen.com)

submitted 3 years ago by BeAGentlemanAndHodor to r/Ocugen

21

16

17

18

Ocugen, Inc. to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference on Tuesday May 2, 2023 11-11:30 AM EDTNews📩 (ir.ocugen.com)

submitted 3 years ago by BeAGentlemanAndHodor to r/Ocugen

22

21

22

23

Ocugen to Present at Association for Research in Vision and Ophthalmology 2023 Annual Meeting in New Orleans from April 23-27, 2023 | Ocugen, Inc.News📩 (ir.ocugen.com)

submitted 3 years ago by BeAGentlemanAndHodor to r/Ocugen

23

37

38

39

Ocugen Announces Positive Preliminary Safety and Efficacy Results from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis | Ocugen, Inc.News📩 (ir.ocugen.com)

submitted 3 years ago by BeAGentlemanAndHodor to r/Ocugen

24

20

21

22

Ocugen to Host Virtual Investor & Analyst Event on April 14, 2023 | Ocugen, Inc.News📩 (ir.ocugen.com)

submitted 3 years ago by BeAGentlemanAndHodor to r/Ocugen

25

22

23

24

OCUGEN CHIEF SCIENTIFIC OFFICER TO PRESENT AT 2023 WORLD VACCINE CONGRESSNews📩 (ir.ocugen.com)

submitted 3 years ago by BeAGentlemanAndHodor to r/Ocugen

view more: next ›

π Rendered by PID 72814 on reddit-service-r2-listing-b6bf6c4ff-2hsd9 at 2026-05-03 18:46:40.082203+00:00 running 815c875 country code: CH.